BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1551871)

  • 1. Alteration of folate analogue transport inward after induced maturation of HL-60 leukemia cells. Molecular properties of the transporter in an overproducing variant and evidence for down-regulation of its synthesis in maturating cells.
    Yang CH; Pain J; Sirotnak FM
    J Biol Chem; 1992 Apr; 267(10):6628-34. PubMed ID: 1551871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.
    Yang CH; Sirotnak FM; Mines LS
    J Biol Chem; 1988 Jul; 263(20):9703-9. PubMed ID: 2838477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
    Sirotnak FM; Poser RE; Barrueco JR
    Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid decline in folylpolyglutamate synthetase activity and gene expression during maturation of HL-60 cells. Nature of the effect, impact on folate compound polyglutamate pools, and evidence for programmed down-regulation during maturation.
    Egan MG; Sirlin S; Rumberger BG; Garrow TA; Shane B; Sirotnak FM
    J Biol Chem; 1995 Mar; 270(10):5462-8. PubMed ID: 7890662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells.
    Roy K; Tolner B; Chiao JH; Sirotnak FM
    J Biol Chem; 1998 Jan; 273(5):2526-31. PubMed ID: 9446553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
    Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
    J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
    Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
    Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system.
    Sirotnak FM; Moccio DM; Yang CH
    J Biol Chem; 1984 Nov; 259(21):13139-44. PubMed ID: 6490649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines.
    Freisheim JH; Ratnam M; McAlinden TP; Prasad KM; Williams FE; Westerhof GR; Schornagel JH; Jansen G
    Adv Enzyme Regul; 1992; 32():17-31. PubMed ID: 1323203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.
    Roy K; Chiao JH; Spengler BA; Tolner B; Yang CH; Biedler JL; Sirotnak FM
    Cancer Genet Cytogenet; 1998 Aug; 105(1):29-38. PubMed ID: 9689927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of folate analogue transport following induced maturation of HL-60 leukemia cells. Early decline in mediated influx, relationship to commitment, and functional dissociation of entry and exit routes.
    Sirotnak FM; Jacobsen DM; Yang CH
    J Biol Chem; 1986 Aug; 261(24):11150-5. PubMed ID: 3460993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
    Zhao R; Assaraf YG; Goldman ID
    J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
    Spinella MJ; Brigle KE; Sierra EE; Goldman ID
    J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
    Sierra EE; Goldman ID
    Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-directed immunoaffinity purification and properties of the one-carbon, reduced folate transporter. Interspecies immuno-cross-reactivity and expression of the native transporter in murine and human tumor cells and their transport-altered variants.
    Chiao JH; Yang CH; Roy K; Pain J; Sirotnak FM
    J Biol Chem; 1995 Dec; 270(50):29698-704. PubMed ID: 8530358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a folate binding protein in L1210 cells grown in low folate medium.
    Jansen G; Kathmann I; Rademaker BC; Braakhuis BJ; Westerhof GR; Rijksen G; Schornagel JH
    Cancer Res; 1989 Apr; 49(8):1959-63. PubMed ID: 2702638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
    Sierra EE; Brigle KE; Spinella MJ; Goldman ID
    Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.
    Henderson GB; Suresh MR; Vitols KS; Huennekens FM
    Cancer Res; 1986 Apr; 46(4 Pt 1):1639-43. PubMed ID: 3948153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity analogues of methotrexate as folate antagonist binding probes. 2. Transport studies, photoaffinity labeling, and identification of the membrane carrier protein for methotrexate from murine L1210 cells.
    Price EM; Freisheim JH
    Biochemistry; 1987 Jul; 26(15):4757-63. PubMed ID: 3663624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.